King Fook Holdings Limited (HKG:0280)

Verve Therapeutics Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	276.77	231.23	301.06	254.52	209.27
Short-Term Investments	176.91	193.3	71.15	144.1	88.13
Trading Asset Securities	-	0.15	0.17	0.15	0.16
Cash & Short-Term Investments	453.68	424.68	372.38	398.77	297.56
Cash Growth	6.83%	14.04%	-6.62%	34.02%	35.50%
Accounts Receivable	13.89	8.05	1.07	3.04	2.04
Other Receivables	3.83	5.2	41.54	3.49	4.25
Receivables	17.72	13.25	42.61	6.53	6.29
Inventory	420.22	414.98	387.38	369.72	415.22
Prepaid Expenses	1.5	3.15	1.55	4.77	4.44
Other Current Assets	6.6	7.91	13.27	2.9	5.56
Total Current Assets	899.72	863.97	817.2	782.69	729.06
Property, Plant & Equipment	50.35	41.8	28.74	62.69	76.54
Long-Term Investments	34.15	0.71	0.33	0.77	1.23
Other Intangible Assets	0.36	0.36	0.36	0.36	0.36
Long-Term Deferred Tax Assets	15	2.6	-	-	-
Other Long-Term Assets	7.07	7.89	7.57	16.79	14.23
Total Assets	1,007	917.32	854.18	863.29	821.41
Accounts Payable	16.81	17.73	9.69	5.91	10.44
Accrued Expenses	21.5	18.39	16.54	12.2	8.67
Short-Term Debt	80.32	58.11	-	44.05	32.71
Current Portion of Leases	31.89	31	28.59	50.8	43.3
Current Unearned Revenue	10.83	19.86	17.92	19.1	13.08
Other Current Liabilities	1.37	2.67	2.21	3.25	3.12
Total Current Liabilities	162.72	147.76	74.95	135.3	111.32
Long-Term Leases	23.62	12.27	12.19	20.24	49.41
Total Liabilities	188.38	162.03	87.21	155.6	160.77
Common Stock	393.35	393.35	393.35	393.35	393.35
Retained Earnings	390.53	329.53	338.92	278.6	231.49
Comprehensive Income & Other	34.34	32.34	34.63	35.65	35.7
Total Common Equity	818.23	755.22	766.9	707.59	660.54
Minority Interest	0.04	0.06	0.08	0.09	0.1
Shareholders' Equity	818.27	755.28	766.98	707.69	660.64
Total Liabilities & Equity	1,007	917.32	854.18	863.29	821.41
Total Debt	135.83	101.38	40.78	115.09	125.42
Net Cash (Debt)	317.85	323.29	331.6	283.68	172.13
Net Cash Growth	-1.68%	-2.51%	16.89%	64.80%	164.08%
Net Cash Per Share	0.35	0.36	0.36	0.31	0.19
Filing Date Shares Outstanding	909.31	909.31	909.36	911.66	912.21
Total Common Shares Outstanding	909.31	909.31	909.36	911.66	912.21
Working Capital	737	716.21	742.25	647.39	617.74
Book Value Per Share	0.90	0.83	0.84	0.78	0.72
Tangible Book Value	817.88	754.86	766.54	707.24	660.18
Tangible Book Value Per Share	0.90	0.83	0.84	0.78	0.72
Machinery	9.54	9.38	-1.83	9.23	9.38
Leasehold Improvements	19.81	19.41	22.08	16.26	10.32

Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.